IA
PRAX icon

IFP Advisors’s Praxis Precision Medicines PRAX Stock Holding History

IFP Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.37K Buy
25
+19
+317% +$6.01K ﹤0.01% 3509
2026
Q1 		$1.93K Hold
6
– – ﹤0.01% 3974
2025
Q4 		$1.77K Buy
6
+3
+100% +$559 ﹤0.01% 3884
2025
Q3 		$159 Buy
+3
New +$145 ﹤0.01% 4444
2025
Q2 		– Sell
-1
Closed -$38 – 3923
2025
Q1 		$38 Hold
1
– – ﹤0.01% 4074
2024
Q4 		$77 Buy
+1
New +$72 ﹤0.01% 4126
2023
Q4 		– Sell
-33
Closed -$855 – 3266
2023
Q3 		$855 Buy
+33
New +$624 ﹤0.01% 3032

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

IFP Advisors's PRAX Position: Q2 2026 in Review

IFP Advisors increased its Praxis Precision Medicines (PRAX) stake by 317% in Q2 2026, buying an estimated $6.01K and bringing the position to 25 shares worth $8.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.

IFP Advisors first reported a position in PRAX in Q3 2023 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • IFP Advisors held 25 shares of Praxis Precision Medicines worth $8.37K as of Q2 2026.
  • IFP Advisors bought 19 Praxis Precision Medicines shares in Q2 2026, an estimated $6.01K.
  • Praxis Precision Medicines made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3509 holding.
  • IFP Advisors first reported a position in Praxis Precision Medicines in Q3 2023 and has held it in 7 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.